Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Radiation / Radiotherapy (RT) & Prostate Cancer

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

In a 10-year update, moderate hypofractionated intensity-modulated radiation therapy (H-IMRT) was not superior to conventionally fractionated IMRT (C-IMRT).
Avkshtol et al. 2020 JCO 38: 1676–1684…

References (Sources)

Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
Vale et al. 2020 The Lancet 396: 1422-1431
Meta-Analysis
Review
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death
Tilki et al. 2021 JCO 39: 2284–2293
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity ﬁndings from an international, randomised, open-label, phase 3, non-inferiority trial
Brand et al. 2019
Prostate re-irradiation: current concerns and future perspectives
Cuccia et al. 2020 Expert Review of Anticancer Therapy 20: 947-956
Review
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
Carrie et al. 2019 Lancet Oncology 20: 1740-1749
Stereotactic Body Radiation (SBRT) in the Management of Clinically Localized Prostate Cancer: Where are We Now?
Roach et al. 2018
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Parker et al. 2020 The Lancet 396: 1413-1421

AI Chat

7/1/2026

Chat with our artificial intelligence: